SCHEMBL25846310

SCHEMBL25846310

CC(C)(CC(=O)O)c1ccc(OCc2cc(F)cc3c2OCO3)cc1

nearest known ligand 0.38

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
PTGER4 P35408 1/20 0.38
FFAR1 O14842 5/20 0.38
NPC1 O15118 1/20 0.36
RAB9A P51151 1/20 0.36
FFAR4 Q5NUL3 5/20 0.35
ALDH1A1 P00352 1/20 0.35
GAA P10253 1/20 0.35
RXRA P19793 4/20 0.35
NR1H2 P55055 3/20 0.35
NR1H3 Q13133 1/20 0.35
SMN1; SMN2 Q16637 1/20 0.35
MAOB P27338 1/20 0.35
ESR1 P03372 1/20 0.35
ESR2 Q92731 1/20 0.35
MEN1 O00255 1/20 0.34
KMT2A Q03164 1/20 0.34
PPARD Q03181 1/20 0.34
NR4A2 P43354 1/20 0.34
RXRB P28702 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25845591 0.90 RAB9A (0.37) PTGER4NPC1RAB9AALDH1A1GAA
SCHEMBL2439272 0.81 GYS1 (0.42) FFAR1FFAR4ALDH1A1GAAMAOB
SCHEMBL25846319 0.75 FFAR4 (0.38) PTGER4FFAR1NPC1RAB9AFFAR4
SCHEMBL2431883 0.72 FFAR4 (0.38) PTGER4FFAR1FFAR4ALDH1A1GAA
SCHEMBL25845939 0.72 PPARD (0.58) FFAR1PPARD
SCHEMBL25845972 0.72 PPARD (0.58) FFAR1PPARD
SCHEMBL2432857 0.71 FFAR4 (0.50) FFAR1FFAR4MAOBKMT2A
SCHEMBL25845606 0.71 NPC1 (0.37) PTGER4NPC1RAB9AFFAR4ALDH1A1
SCHEMBL25846301 0.71 PPARD (0.53) FFAR1PPARD
SCHEMBL29043606 0.70 ALDH1A1 (0.47) NPC1RAB9AALDH1A1MEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230339919-A1 BENZO OXYGEN-CONTAINING HETEROCYCLIC COMPOUNDS AND MEDICAL APPLICATION THEREOF AB Pharma Ltd. (CN) 2023-10-26 US disclosed
US-20230339919-A1 BENZO OXYGEN-CONTAINING HETEROCYCLIC COMPOUNDS AND MEDICAL APPLICATION THEREOF AB Pharma Ltd. (CN) 2023-10-26 US disclosed
EP-4212528-A1 BENZO OXYGEN-CONTAINING HETEROCYCLIC COMPOUND AND MEDICAL APPLICATION THEREOF AB Pharma Ltd. (CN) 2023-07-19 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230339919-A1 BENZO OXYGEN-CONTAINING HETEROCYCLIC COMPOUNDS AND MEDICAL APPLICATION THEREOF GPR55, GPR65, GPR4 PTGER4 151/4885FFAR1 52/4885NPC1 1707/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.